Daniel C. Javitt, 10% Owner at NRX Pharmaceuticals, Inc. (NRXP), sold 22,171 shares at $1.50 ($33K) on 2022-11-29, disclosed to the SEC on 2022-12-01.
Scheduled sale ($33k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.50 | 13,730 | $21K | 61.9% |
| 2 | $1.50 | 8,441 | $13K | 38.1% |
| Total | $1.50 avg | 22,171 | $33K | 100% |
| Filing → |
| NRXP | SELL | 2022-08-02 | $1.6M | — | Filing → |
| NRXP | SELL | 2022-06-07 | $608K | — | Filing → |